Price
No data yet.
Social Signal Score
Analyst Ratings
1 analystRevenue
$3.69M+456.80%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Brian J. Kieser
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 19
- Beta
- 0.75
- Country
- US
- Piotroski score
- 1 / 9 (Weak)
- Altman Z-score
- -1.68
Financials
Revenue
$3.69M+456.8%Net Income
$-3.63MEBITDA
$-398.0KFree Cash Flow
$-2.27M-3347.1%EPS (diluted)
$-0.40Shares Outstanding (diluted)
9.01M+62.0%Operating Expenses
$3.61MCash & Debt
$492.0KReturn of Capital
$0.00Revenue by Segment (annual)
$2.22MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $11.42M | $-3.00M | $-0.38 |
| 2024 | $8.69M | $-3.28M | $-0.50 |
| 2023 | $4.09M | $-3.16M | $-0.56 |
| 2022 | $2.05M | $-4.75M | $-0.85 |
| 2021 | $1.55M | $-4.31M | $-0.77 |
| 2020 | $674.0K | $-2.26M | $-0.41 |
| 2019 | $717.0K | $-1.92M | $-0.35 |
| 2018 | $2.21M | $-1.89M | $-0.34 |
| 2017 | $1.99M | $-953.0K | $-0.17 |
| 2016 | $2.15M | $-1.78M | $-0.32 |
Valuation
NXGLhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
120+20.00%Social Signal Score
Mentions (3)
- Newsseekingalpha.com·6h ago·Positive
NEXGEL, Inc. (NXGL) Discusses Strategic Platform Reorganization and Refocus on Medical Device and Biomedical Innovation Transcript NEXGEL, Inc. (NXGL) Discusses Strategic Platform Reorganization and Refocus on Medical Device and Biomedical Innovation Transcript
View source ↗ - Newsglobenewswire.com·1d ago·Neutral
NEXGEL Announces Dial-In Details for Investor Update Call LANGHORNE, Pa., Sept. 23, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a company with a patient centric medical technology sales and marketing team working closely with clinicians to provide solutions that drive better outcomes, streamline care, and elevate the patient experience, today announced dial-in details for its previously announced investor update call to be held on September 24, 2026, at 4:…
View source ↗ - Newsglobenewswire.com·8d ago·Neutral
NEXGEL Announces Date for Investor Update Call LANGHORNE, Pa., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a company with a patient centric medical technology sales and marketing team working closely with clinicians to provide solutions that drive better outcomes, streamline care, and elevate the patient experience, today announced the date for the investor update call referenced in its August 17, 2026 earnings release, at which time the Company …
View source ↗
Earnings
Tue, Nov 10(in 7 weeks)
Consensus estimate $-0.24 per share
Typical surprise -22.2% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Aug 14$-0.40 vs $-0.12miss
- Wed, May 13$-0.11 vs $-0.07miss
- Tue, Mar 31$-0.11 vs $-0.09miss
- Tue, Nov 11$-0.08 vs $-0.09beat
- Tue, Aug 12$-0.09 vs $-0.01miss
- Tue, May 13$-0.09 vs $-0.10beat
Estimates and results for NXGL via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by NXGL officers and directors.
- Bought
- $2.2m
- Sold
- $245k
24 trades
35 trades
- Levy Adam R.sold
- Levy Adam R.sold
- Levy Adam R.sold
- Levy Adam R.sold
- Levy Adam R.sold
- Levy Adam R.sold
- Levy Adam R.sold
- Levy Adam R.sold
41 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in NXGL.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.